2018-10-09 |
2018-10-09 |
PS
Planned sale
|
Andriole Michael T.
Chief Financial Officer
Officer
|
635
-0.5%
15.85
10,065
USD
|
635
-0.5%
|
15.85
|
10,065
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Low Philip S
Chief Science Officer
Executive Director
|
5,928
-1.8%
15.56
92,238
USD
|
5,928
-1.8%
|
15.56
|
92,238
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Armour Alison A.
Chief Medical Officer
Officer
|
9,111
-8.3%
15.56
141,748
USD
|
9,111
-8.3%
|
15.56
|
141,748
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
7,022
-11.1%
15.56
109,287
USD
|
7,022
-11.1%
|
15.56
|
109,287
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
9,028
-6.9%
15.56
140,437
USD
|
9,028
-6.9%
|
15.56
|
140,437
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Andriole Michael T.
Chief Financial Officer
Officer
|
17,283
-11.5%
15.55
268,783
USD
|
17,283
-11.5%
|
15.55
|
268,783
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Sherman Michael A.
President and CEO
Executive Director
|
28,146
-7.5%
15.55
437,752
USD
|
28,146
-7.5%
|
15.55
|
437,752
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Chelius Erik C.
Vice President CMC
Officer
|
4,514
-8.3%
15.56
70,243
USD
|
4,514
-8.3%
|
15.56
|
70,243
USD
|
|
2018-10-09 |
2018-10-05 |
PS
Planned sale
|
Parker Katherine
VP of Human Resources
Officer
|
6,771
-8.8%
15.55
105,316
USD
|
6,771
-8.8%
|
15.55
|
105,316
USD
|
|
2018-08-29 |
2018-08-29 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
4,696
-3.5%
20.00
93,920
USD
|
4,696
-3.5%
|
20.00
|
93,920
USD
|
|
2018-08-29 |
2018-08-28 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
7,892
-11.1%
20.00
157,840
USD
|
7,892
-11.1%
|
20.00
|
157,840
USD
|
|
2018-08-29 |
2018-08-28 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
Officer
|
12,670
-8.9%
20.00
253,403
USD
|
12,670
-8.9%
|
20.00
|
253,403
USD
|
|
2018-08-22 |
2018-08-20 |
PS
Planned sale
|
Taylor Beth
VP Finance & Chief Acctg Offcr
Officer
|
285
-0.4%
18.20
5,187
USD
|
285
-0.4%
|
18.20
|
5,187
USD
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
Armour Alison A.
Chief Medical Officer
Officer
|
1,414
-1.3%
15.98
22,589
USD
|
1,414
-1.3%
|
15.98
|
22,589
USD
|
|
2018-06-13 |
2018-06-12 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
|
13,089
-9.1%
15.06
197,058
USD
|
13,089
-9.1%
|
15.06
|
197,058
USD
|
|
2018-03-12 |
2018-03-09 |
PS
Planned sale
|
Leamon Christopher P
Vice President of Research
|
5,036
-3.4%
9.07
45,677
USD
|
5,036
-3.4%
|
9.07
|
45,677
USD
|
|
2018-01-02 |
2017-12-28 |
S
Sale
|
Low Philip S
Chief Science Officer
Executive Director
|
50,511
-14.3%
4.41
222,824
USD
|
50,511
-14.3%
|
4.41
|
222,824
USD
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
Leamon Christopher P
Vice President of Research
|
5,037
-3.8%
5.05
25,434
USD
|
5,037
-3.8%
|
5.05
|
25,434
USD
|
|
2017-12-04 |
2017-12-01 |
S
Sale
|
Leamon Christopher P
Vice President of Research
|
18,194
-12.1%
5.03
91,549
USD
|
18,194
-12.1%
|
5.03
|
91,549
USD
|
|
2017-11-14 |
2017-11-13 |
B
Purchase
|
Low Philip S
Chief Science Officer
Executive Director
|
5,600
+2.0%
4.84
27,104
USD
|
5,600
+2.0%
|
4.84
|
27,104
USD
|
|
2017-01-04 |
2016-12-30 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
23,244
-25.8%
2.55
59,272
USD
|
23,244
-25.8%
|
2.55
|
59,272
USD
|
|
2016-05-12 |
2016-05-10 |
B
Purchase
|
Low Philip S
Chief Science Officer
Executive Director
|
11,375
+5.5%
3.52
40,040
USD
|
11,375
+5.5%
|
3.52
|
40,040
USD
|
|
2016-01-20 |
2016-01-19 |
B
Purchase
|
MIDDLETON FRED A
Non-Executive Director
|
10,000
+5.2%
2.79
27,900
USD
|
10,000
+5.2%
|
2.79
|
27,900
USD
|
|
2016-01-20 |
2016-01-15 |
B
Purchase
|
MIDDLETON FRED A
Non-Executive Director
|
20,000
+11.7%
2.80
56,000
USD
|
20,000
+11.7%
|
2.80
|
56,000
USD
|
|
2015-03-05 |
2015-03-03 |
S
Sale
|
Nguyen Binh
VP of Medical Affairs
Officer
|
29,883
-51.3%
5.79
172,987
USD
|
29,883
-51.3%
|
5.79
|
172,987
USD
|
|
2014-08-13 |
2014-08-11 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
21,479
-77.5%
7.00
150,353
USD
|
21,479
-77.5%
|
7.00
|
150,353
USD
|
|
2013-09-16 |
2013-09-12 |
S
Sale
|
Meek David D.
Chief Commercial Officer
Officer
|
10,000
-100.0%
15.50
155,000
USD
|
10,000
-100.0%
|
15.50
|
155,000
USD
|
|
2013-09-04 |
2013-08-30 |
S
Sale
|
Ritter Allen R
VP of Manufacturing/CMC
Officer
|
6,000
-25.3%
14.36
86,160
USD
|
6,000
-25.3%
|
14.36
|
86,160
USD
|
|
2013-08-08 |
2013-08-06 |
S
Sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
7,000
-100.0%
17.29
121,030
USD
|
7,000
-100.0%
|
17.29
|
121,030
USD
|
|
2013-05-29 |
2013-05-28 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
131
-0.2%
14.25
1,867
USD
|
131
-0.2%
|
14.25
|
1,867
USD
|
|
2013-05-29 |
2013-05-28 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,569
-0.2%
14.25
22,358
USD
|
1,569
-0.2%
|
14.25
|
22,358
USD
|
|
2013-05-29 |
2013-05-24 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
630
-1.1%
14.07
8,864
USD
|
630
-1.1%
|
14.07
|
8,864
USD
|
|
2013-05-29 |
2013-05-24 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
7,570
-1.1%
14.07
106,510
USD
|
7,570
-1.1%
|
14.07
|
106,510
USD
|
|
2013-05-22 |
2013-05-22 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,259
-2.2%
14.39
18,117
USD
|
1,259
-2.2%
|
14.39
|
18,117
USD
|
|
2013-05-22 |
2013-05-22 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
15,141
-2.2%
14.39
217,879
USD
|
15,141
-2.2%
|
14.39
|
217,879
USD
|
|
2013-05-22 |
2013-05-21 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
845
-1.5%
14.31
12,092
USD
|
845
-1.5%
|
14.31
|
12,092
USD
|
|
2013-05-22 |
2013-05-21 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
10,155
-1.5%
14.31
145,318
USD
|
10,155
-1.5%
|
14.31
|
145,318
USD
|
|
2013-05-22 |
2013-05-20 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
967
-1.7%
14.42
13,944
USD
|
967
-1.7%
|
14.42
|
13,944
USD
|
|
2013-05-22 |
2013-05-20 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
11,633
-1.7%
14.42
167,748
USD
|
11,633
-1.7%
|
14.42
|
167,748
USD
|
|
2013-05-21 |
2013-05-17 |
S
Sale
|
Nguyen Binh
VP of Clinical Affairs
Officer
|
17,300
-100.0%
14.42
249,466
USD
|
17,300
-100.0%
|
14.42
|
249,466
USD
|
|
2013-05-20 |
2013-05-17 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,121
-1.9%
14.37
16,109
USD
|
1,121
-1.9%
|
14.37
|
16,109
USD
|
|
2013-05-20 |
2013-05-17 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
13,479
-1.9%
14.37
193,693
USD
|
13,479
-1.9%
|
14.37
|
193,693
USD
|
|
2013-05-20 |
2013-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,735
-2.9%
14.44
25,053
USD
|
1,735
-2.9%
|
14.44
|
25,053
USD
|
|
2013-05-20 |
2013-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
20,865
-2.9%
14.44
301,291
USD
|
20,865
-2.9%
|
14.44
|
301,291
USD
|
|
2013-05-16 |
2013-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,536
-2.5%
14.43
22,164
USD
|
1,536
-2.5%
|
14.43
|
22,164
USD
|
|
2013-05-16 |
2013-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
18,464
-2.5%
14.43
266,436
USD
|
18,464
-2.5%
|
14.43
|
266,436
USD
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
1,551
-2.4%
14.94
23,172
USD
|
1,551
-2.4%
|
14.94
|
23,172
USD
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
18,649
-2.4%
14.94
278,616
USD
|
18,649
-2.4%
|
14.94
|
278,616
USD
|
|
2013-05-16 |
2013-05-14 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
5,000
-33.2%
14.70
73,500
USD
|
5,000
-33.2%
|
14.70
|
73,500
USD
|
|
2013-02-26 |
2013-02-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,993
-100.0%
9.70
19,332
USD
|
1,993
-100.0%
|
9.70
|
19,332
USD
|
|
2013-02-26 |
2013-02-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
109
-100.0%
9.70
1,057
USD
|
109
-100.0%
|
9.70
|
1,057
USD
|
|
2013-02-20 |
2013-02-19 |
PS
Planned sale
|
Ritter Allen R
VP of Manufacturing/CMC
Officer
|
500
-14.4%
10.03
5,015
USD
|
500
-14.4%
|
10.03
|
5,015
USD
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,659
-100.0%
9.56
15,860
USD
|
1,659
-100.0%
|
9.56
|
15,860
USD
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
443
-100.0%
9.56
4,235
USD
|
443
-100.0%
|
9.56
|
4,235
USD
|
|
2013-01-29 |
2013-01-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
107
-100.0%
9.56
1,023
USD
|
107
-100.0%
|
9.56
|
1,023
USD
|
|
2012-12-28 |
2012-12-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,102
-100.0%
9.05
19,023
USD
|
2,102
-100.0%
|
9.05
|
19,023
USD
|
|
2012-12-28 |
2012-12-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
107
-100.0%
9.05
968
USD
|
107
-100.0%
|
9.05
|
968
USD
|
|
2012-11-27 |
2012-11-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
1,926
-100.0%
8.72
16,795
USD
|
1,926
-100.0%
|
8.72
|
16,795
USD
|
|
2012-11-27 |
2012-11-26 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
283
-100.0%
8.72
2,468
USD
|
283
-100.0%
|
8.72
|
2,468
USD
|
|
2012-10-29 |
2012-10-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,209
-100.0%
9.71
21,449
USD
|
2,209
-100.0%
|
9.71
|
21,449
USD
|
|
2012-10-01 |
2012-09-28 |
S
Sale
|
Low Philip S
Chief Science Officer
Executive Director
|
34,000
-8.1%
9.99
339,810
USD
|
34,000
-8.1%
|
9.99
|
339,810
USD
|
|
2012-09-27 |
2012-09-25 |
PS
Planned sale
|
Lovejoy Chandra D
VP of Regulatory Affairs
Officer
|
2,209
-100.0%
10.28
22,709
USD
|
2,209
-100.0%
|
10.28
|
22,709
USD
|
|
2012-08-17 |
2012-08-16 |
S
Sale
|
Leamon Christopher P
Vice President of Research
Officer
|
10,000
-39.9%
9.65
96,535
USD
|
10,000
-39.9%
|
9.65
|
96,535
USD
|
|
2012-06-07 |
2012-06-06 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
24,181
-27.4%
6.60
159,674
USD
|
24,181
-27.4%
|
6.60
|
159,674
USD
|
|
2012-06-07 |
2012-06-06 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
290,719
-27.4%
6.60
1,919,705
USD
|
290,719
-27.4%
|
6.60
|
1,919,705
USD
|
|
2012-06-07 |
2012-06-05 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
783
-0.9%
6.60
5,170
USD
|
783
-0.9%
|
6.60
|
5,170
USD
|
|
2012-06-07 |
2012-06-05 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
9,417
-0.9%
6.60
62,180
USD
|
9,417
-0.9%
|
6.60
|
62,180
USD
|
|
2012-05-18 |
2012-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
2,142
-2.3%
6.65
14,246
USD
|
2,142
-2.3%
|
6.65
|
14,246
USD
|
|
2012-05-18 |
2012-05-16 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
25,758
-2.3%
6.65
171,306
USD
|
25,758
-2.3%
|
6.65
|
171,306
USD
|
|
2012-05-16 |
2012-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
3,071
-3.3%
6.68
20,510
USD
|
3,071
-3.3%
|
6.68
|
20,510
USD
|
|
2012-05-16 |
2012-05-15 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
36,929
-3.3%
6.68
246,638
USD
|
36,929
-3.3%
|
6.68
|
246,638
USD
|
|
2012-05-16 |
2012-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
8,215
-8.0%
6.94
56,974
USD
|
8,215
-8.0%
|
6.94
|
56,974
USD
|
|
2012-05-16 |
2012-05-14 |
S
Sale
|
HANHAM ANN
Non-Executive Director
|
98,785
-8.0%
6.94
685,113
USD
|
98,785
-8.0%
|
6.94
|
685,113
USD
|
|
2011-12-22 |
2011-12-21 |
B
Purchase
|
SANDERLING VENTURES MANAGEMENT V
Major owner
|
2,200
+6.7%
3.16
6,952
USD
|
2,200
+6.7%
|
3.16
|
6,952
USD
|
|
2011-12-22 |
2011-12-21 |
B
Purchase
|
Sanderling Venture Partners V, LP
Major owner
|
217,800
+33.3%
3.16
688,248
USD
|
217,800
+33.3%
|
3.16
|
688,248
USD
|
|